Zobrazeno 1 - 10
of 34
pro vyhledávání: '"AE-IPF"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are the leading cause of mortality among patients with IPF. There is still a lack of effective treatments for AE-IPF, resulting in a hospitalization mortality rate as high as 70%–80%. To
Externí odkaz:
https://doaj.org/article/fdee44aaa6ec46218d8843945e0733eb
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-7 (2024)
Abstract Objective To develop and validate a diagnosis model to inform risk stratified decisions for idiopathic pulmonary fibrosis patients experiencing acute exacerbations (AE-IPF). Methods In this retrospective cohort study performed from 1 January
Externí odkaz:
https://doaj.org/article/629bccfbd4e849e299f7327db453fb9f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zhang Hailong, Li Jiansheng, Guo Wen, Wang Lu, Zhang Dong, Zhao Limin, Zhou Miao, Luo Weixian
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background At present, there is short of effective treatment for acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). The treatment of IPF with traditional Chinese medicine (TCM) has some advantages. However, the evidence is unclear
Externí odkaz:
https://doaj.org/article/512d76fbc4cb4950b2ae390baaf7b6bb
Autor:
Dong Weng, Zhao-Fang Yin, Shan-Shan Chen, Xian He, Nan Li, Tao Chen, Hui Qiu, Meng-Meng Zhao, Qin Wu, Nian-Yu Zhou, Li-Qin Lu, Dan-Li Tang, Jia-Cui Song, Hui-Ping Li
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1419-1431 (2021)
Glucocorticoid (GC) hormone has been commonly used to treat systemic inflammation and immune disorders. However, the side effects associated with long-term use of high-dose GC hormone limit its clinical application seriously. GC hormone that can spec
Externí odkaz:
https://doaj.org/article/3ff7c95d3fd84b3cb63d0ffc046af6f2
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 206:219-221
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6208815943d1daabf466ff81cbdfba5
https://doi.org/10.1164/rccm.202112-2765le
https://doi.org/10.1164/rccm.202112-2765le
Publikováno v:
Chest
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive scar tissue formation. An acute exacerbation of IPF (AE-IPF) is a clinically significant respiratory decompensation that accounts for a significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ce2b28dd6d16f39241348e1de3a2f3
http://europepmc.org/articles/PMC8814523
http://europepmc.org/articles/PMC8814523
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Weixian Luo, Limin Zhao, Miao Zhou, Lu Wang, Wen Guo, Hailong Zhang, Jian-sheng Li, Dong Zhang
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-8 (2022)
Trials
Trials
Background At present, there is short of effective treatment for acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). The treatment of IPF with traditional Chinese medicine (TCM) has some advantages. However, the evidence is unclear whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa957703702a50170985abc770eeada
https://doi.org/10.21203/rs.3.rs-74902/v1
https://doi.org/10.21203/rs.3.rs-74902/v1
